Korro Bio Inc
KRRO15.300USD
+1.450+10.47%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
143.65MMarket Cap
LossP/E TTM
Korro Bio Inc
15.300
+1.450+10.47%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
Total equity
Cash, cash equivalents and short-term investments
-17.18%114.95M
--126.09M
--137.00M
--157.43M
--138.80M
- Cash and cash equivalents
-53.79%64.14M
--55.64M
--63.21M
--91.15M
--138.80M
-Short-term investments
--50.81M
--70.45M
--73.79M
--66.28M
----
Receivables
--1.92M
--1.70M
--10.00M
----
----
-Accounts and notes receivable
--1.92M
--1.70M
--10.00M
----
----
Prepaid expenses
31.86%4.36M
--3.74M
--4.02M
--4.42M
--3.31M
Other current assets
-100.00%0.00
--0.00
--1.77M
--1.77M
--3.55M
Total current assets
-16.77%121.23M
--131.53M
--152.78M
--163.63M
--145.66M
Non-current assets
Net Fixed Assets
8.39%50.35M
--51.55M
--53.13M
--49.54M
--46.46M
-Fixed Assets
7.06%58.91M
--58.87M
--63.01M
--58.82M
--55.02M
-Accumulated depreciation
-0.16%8.55M
--7.33M
--9.88M
--9.28M
--8.57M
Other non-current assets
12.00%6.58M
--6.20M
--5.52M
--6.08M
--5.87M
Total non-current assets
54.73%80.97M
--94.71M
--90.76M
--85.96M
--52.33M
Total assets
2.13%202.21M
--226.24M
--243.54M
--249.59M
--197.99M
Liabilities
Current liabilities
-Other payables
252.14%493.00K
--277.00K
--186.00K
--247.00K
--140.00K
Accrued expenses
-29.34%3.15M
--5.89M
--4.71M
--5.43M
--4.46M
Deferred liabilities
--2.75M
--3.51M
--2.20M
----
----
Other current liabilities
2217.14%3.24M
--3.79M
--2.39M
--247.00K
--140.00K
Total current liabilities
16.54%12.88M
--14.96M
--13.61M
--12.32M
--11.05M
Non-current liabilities
Long-term debt and lease liabilities
23.64%42.88M
--43.48M
--41.78M
--38.00M
--34.68M
-Long-term lease liabilities
23.64%42.88M
--43.48M
--41.78M
--38.00M
--34.68M
Deferred liabilities
--6.05M
--5.91M
--7.80M
----
----
Other non-current liabilities
738.75%7.49M
--7.38M
--8.52M
--1.18M
--893.00K
Total non-current liabilities
41.59%50.37M
--50.87M
--50.30M
--39.19M
--35.57M
Total liabilities
35.65%63.25M
--65.83M
--63.91M
--51.51M
--46.63M
Shareholders' equity
Common equity
21.12%428.67M
--426.73M
--424.44M
--422.44M
--353.92M
Retained earnings
-43.15%-289.97M
---266.59M
---245.39M
---224.39M
---202.56M
Capital reserves
21.12%428.66M
--426.72M
--424.44M
--422.44M
--353.91M
Gains losses not affecting retained earnings
--264.00K
--268.00K
--574.00K
--21.00K
----
Total equity
-8.19%138.96M
--160.41M
--179.63M
--198.08M
--151.36M
Currency unit
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
